Lets try that again.
Year....Dose Sales..Sales Market...Pen%
2011/2....6140......$92,100,000....0.7
1.........8596......$128,940,000...1.0
2.........12034.....$180,516,000...1.4
3.........16848.....$252,722,400...1.9
Based on profit increasing 20% more that dose sales (on an 80% gross this I think is reasonable), the figures came out at..
Share.....Price Profit M$
8..........$22,000,000
14.........$36,960,000
23.........$62,092,800
39.........$104,315,904
Ann: Clinical Study Result , page-21
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.8¢ | 17.5¢ | $68.91K | 393.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3966005 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 2611882 | 37 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |